Signalling pathways Flashcards
What are the different ways cells communicate?
- Direct contact
- between neighbouring cells
- might have gap junctions in the membrane
- cells might produce molecules that enter the other cells which can activate or inhibit responses
-cells might might complementary proteins that can bind with each other to activate response/pathway
- Contact over larger distances
- paracrine signalling = releasing signals in the extracellular space
- endocrine signalling = releasing signals into blood
- autocrine signalling
What is the general mechanism in cell signalling (prototypic pathway)?
- Molecule binds to receptor (reception)
- Receptor can change conformation, become phosphorylated or dimerise (transduction)
- Response caused by transduction
- Feedback (negative - shut off pathway, positive - reinforce effects of pathway)
How can we classify pathways?
-Where signal is coming from
- Paracrine (morphogens)
- Hedgehog, Wnt, TGFB, receptor tyrosine kinase - Cell-cell contact
- Eph/ephrins, semaphorins - Extracellular
- Wnt pathway - Mechanical cues and cell polarity pathways
- Hippo pathway
How is the hippo pathway involved in first cell fate?
- 1st cell fate = whether the cells in the embryo differentiate into trophoectoderm or embryoblasts
- This is controlled by position of cell in the embryo and its polarity - these signal via the Hippo pathway
- As the cells become specified as either inner cell mass or trophoectoderm, they start expressing different transcription factors
- ICM expresses Oct3, Oct4, Sox2, Sall2, Nanog
- TE expresses GATA4, Cdx2 and TEAD4
- TEAD4 is the key regulator of TE formation. Trophoblasts can’t express Cdx2 and GATA4 without TEAD4 expression
- TEAD4 is only activated in TE via the hippo pathway
How was the hippo pathway discovered?
- First identified in Drosophila as a tumour suppressor gene
- Mutation causes overgrowth, leading to huge tumours throughout body - hence the name hippo
- Mammalian homologues were identified - these are Mst1 and Mst2
-Loss of function of Mst1/Mst2 can cause overgrowth
How does the hippo signalling work?
- Main different of trophoectoderm and ICM at the 16 cell stage is their relative position in the embryo (TE is on the outside, ICM is in the middle)
- We think hippo pathway is inactivated by trophoectoderm cells having a polar apical surface. These polarised cells inactivate the kinase pathway.
- This also determines whether the cells are polar or not
- The future trophoectoderm have a free surface so become polar
- The future ICM are completely surrounded so bind to other cells so remain non-polar
- The difference in polarity is what determines Hippo pathway
In the ICM:
- Mst (encoded by Hippo gene) phosphorylates Lats (hippo pathway activated)
- Lats phosphorylate Yap
- Yap is a co-transcriptional regulator that binds TEAD4
- Phosphorylated Yap can’t trans locate into nucleus
- Hence, Yap can’t bind TEAD4 so it can’t activate transcription of trophoectoderm factors (Cdx2, GATA4)
Troophoectoderm cells:
- Mst not active (hippo pathway not active)
- Mst doesn’t phosphorylate Lats
- Lats can’t phosphorylate Yap
- Yap can translocate to nucleus and bind TEAD4
- Yap-TEAD4 complex allows transcription of Cdx2 and GATA4
What is the Eph/Ephrin signalling pathway?
- This signalling pathway is important for segregation of group of cells with different identities during embryogenesis
- Plays role in axon guidance, forming tissue boundaries, cell migration and body segmentation
- Eph receptors (called Ephs) are transmembrane proteins from the receptor tyrosine kinase family
- Can only bind to either Ephrin-A or Ephrin-B, except EphA4 (receptor) which can bind to both types of ligands
-Ephrin ligands = are type A or B depending on the receptor they bind to
-Ephrin type A ligand = attached to membrane by lipid modification (GPI)
and lack cytosolic domain
-Ephrin type B ligand= transmembrane protein attached to membrane by a single transmembrane domain that contains a short cytosolic PDZ binding motif
- There are 5 ephrin-A ligands (A1-A5) that interact with 9 EphAs (EphA1-8, EphA10)
- Bind with high affinity (lock and key mechanism)
- There are 3 ephrin-B ligands (A1-A3) and 5 EphBs (EphB1-4, EphB6)
- Bind with weaker affinity (induced fit mechanism)
- The interaction between ephrin ligands EphRs leads to bidirectional response - in both the receiving and signalling cell
- Binding of ephrin ligand to EphR can cause a forward signal (a response in the EphR cell), a reverse signal (response in the ephrin-ligand cell) or bidirectional signal
Forward signalling
- Phosphotyrosine mediated recruitment and tyrosine phosphorylation
- Phosphorylation of intracellular effector proteins
- These then regulate activity of Rho GTPases, hence regulate the cytoskeletal dynamics
Reverse signalling
- Ephrin-A reverse signalling involves interaction with co-rectories that can mediate attraction of repulsion of cells
- Ephrin-B reverse signalling occurs via phosphotyrosine and PDZ domain dependent pathway
Termination of pathway:
-Cleavage of ephrin ligand using proteases or endocytosis of the ligand into cell
Key point: Because both the receptor and ligand are membrane bound, the intracellular pathways can only be activated by direct cell-cell interacting
How is the Eph/Ephrin signalling involved in axon guidance?
- Important for migration neuronal axons to their destination
- Controls guidance of axons through their ability to inhibit the survival of axonal growth cones
- This repels the migrating axon away from the site of Eph-ephrin activation
- The growth of cones migrating axons don’t respond to absolute levels of Eph-ephrin, but the relative levels of EphR and ephrin expression - this allows migrating axons that express EphRs or ephrins to be directed along gradients of EphR or Ephrin expressing cells towards a direction where axonal growth is no longer completely inhibited
- Although EphR-ephrin activation is associated with decreased come survival and repulsion of migrating axons, it has recently been demonstrated that growth cone survival doesn’t depend on just EphR-ephrin activation but on the differential effects of forward or reverse signalling.
What is the notch-delta pathway (lateral inhibition)?
- Very important in neurogenesis
- It is used to make 2 types of cells from a homogeneous field of cells
- Directs specification of complementary fates in tissues where it is expressed
- The process is called lateral inhibition (allows cells to adopt different fates)
-Only certain cells within the field are selected and fated to become neurones
- All cells express Notch (the receptor) and Delta (the ligand)
- This means 2 adjacent cells are able to signal to each other
- Sending cell has more delta than notch
- Receiving cell has more notch than delta
- Notch is able to repress the activity of delta, therefore when notch is activated in a cell, delta is repressed
- If the levels of delta were the same in all cells, everything would be switched off and no signalling would occur
- The levels of delta vary between cells - they’re similar but not identical (this is completely random)
- The result of this is that the small difference can be amplified very quickly
- Cells with slightly higher levels of delta will activate more Notch on other cells, leading to more repression of Delta in adjacent cells
- This is lateral inhibition
- The cells that have lots of delta are the ones within the field that sill become neurones as they are able to activate more notch in adjacent cells, which will in turn repress delta in these cells
- This also happens in myogenesis, not just neurogenesis
- If there is no notch activity, there is no lateral inhibition. This is because notch represses delta, hence, with no notch, cells will produce a lot of delta so all cells become neurones.
- It’s the lack of delta expression in laterally inhibited cells that means some cells in the field do not become neurones
What is the molecular mechanism of notch-delta pathway?
- Notch receptors are single pass transmembrane receptor proteins with a large extracellular domain and smaller intracellular domain
- When no ligand is bound to notch, CSL (a transcription factor in the nucleus) is complexed with repressor proteins, preventing expression of the target genes
- When a ligand (delta) binds to notch on the extracellular domain, proteolytic cleavage occurs, separating the extracellular domain from the rest of the protein - this is first cleavage
- This leads to the second cleavage, where the intracellular domain is cleaved by enzymes of the Presenilin complex
- The free intracellular domain is translocated into the nucleus and binds to the CSL complex
- This induces a conformational change that activates the CSL complex as repressor proteins can no longer bind
- The co-activator protein Mastermind is then recruited (with other co-activator factors) and binds to the complex
- This CSL complex can now initiate transcription of the target genes
What are morphogens?
- Diverse signalling molecules
- They are secreted by signalling centres of embryo
- Activates all pathways
- In the embryo, signalling molecules are often produced in a specific region and disperse thoroughout the tissue creating concentration gradients
- Cells will respond differently depending on the level of signal they detect (acquiring different fates at different concentrations)
- They provide positional information within embryo
How are morphogens important in the neural tube?
- Image shoes vertebrate neural tube in chick embryo
- There are different signalling centres
- Anterior neural boundary synthesises FGF8
- Zona limit and intrathalamica and floor plate produce Shh
- Mid-hindbrain boundary and roof plate produce Wnt1 and FGF8
- Ectoderm overlying neural tube produces BMPs
-The different morphogen gradient produced by these signalling centres define dorsoventral and anteroposterior axes of developing embryo
What morphogens are involved in the RTK, TGFB superfamily and direct pathways?
RTKs
- PDGF
- EGF
- FGF
- VEGF
TGFB superfamily (serine/threonine)
- TGF
- BMP
- Activin
Direct pathways
- Shh
- Wnt
What is RTK signalling?
- FGF, PDGF, EGF, VEGF are associated with tyrosine kinase receptors
- They all work in the way
- Receptors exist as monomers with an extracellular binding domain, a single transmembrane domain, and a intracellular domain that is coupled to a tyrosine kinase
- They dimerise upon ligand binding leading to autophosphorylation and activation of tyrosine kinase domain
- The phosphorylated tyrosines can then act as docking sites for whole range of proteins
- In the FGF pathway, Grb and Sos bind to the phosphorylated tyrosines
- Sos is a guanine exchange factor (GEF) that activates GTPases
- Sos and Grb recruit Ras (a GTPase) in the cell membrane
- Activated Ras will activate the first serine/threonine kinase (Raf) in the transduction pathway
- Raf then phosphorylates the next kinase MAPKK which goes on to phosphorylate MAPK
- MAPK can then phosphorylate and activate other kinases, or enter the nucleus and phosphorylate transcription factors, activating gene expression
Dimerisation upon ligand binding —> Autophosphorylation of tyrosine domain—> Recruitment of Grb and Sos —> Activate Ras —> Activate serine/threonine kinase (Raf)—> Activate MAPKK —> Activate MAPK
What are tyrosine kinase associated receptors?
- Similar to RTKs
- Produce a similar response
- Main difference is that the receptor doesn’t have any tyrosine kinase activity itself, instead, the intracellular domain is bound to other kinases such as JAK
- When the receptor interacts with the ligand, it dimerses, cross phosphorylation occurs and then activation occurs
- Induces signal transduction, leading to a response